Most cancer patients lack actionable driver mutations or other bio-markers. Thus, most cancer patients receive chemotherapy, which is still a hit or miss experiment today. SageMedic’s has developed its genome-free SAGE Direct Platform™, which will help the millions of cancer patients who don’t have a driver-mutations to identify the treatment that’s most effective for them. This redefines precision medicine and we believe that the impact of our SAGE Direct Platform™ is considerably bigger than that of any new drug under development.
The 17th PMWC offers exhibition options for emerging and established companies and organizations to promote their products and services. This is an opportunity for exhibitors to interact with PMWC participants actively involved and leading the personalized medicine revolution. In addition to standard networking, PMWC holds dedicated breaks from talks dedicated to exhibition where heavy foot-traffic flows:
This conference will take place at the Santa Clara Convention Center and as such will house a more traditional exhibition layout. The size spaces we offer are 10’x10′, 20’x10′ inline spaces & 22’x20′, 50’x20′ island spaces.
“As a commercial leader, I can testify to the great ROI we received this year. The PMWC conference provides us with a unique cross section of precision medicine key stakeholders and multiple ways to engage with them across the 3 day PMWC program. Our exhibit serves as a quality networking environment that puts us easily in touch with relevant new sales leads – at the right decision-making level.”
Head of Life Science and Healthcare, PMWC 2019 Exhibitor